The Centers for Medicare & Medicaid Services today awarded $347 million in contracts to 16 organizations, including the AHA’s Health Research & Educational Trust, to continue efforts to reduce hospital-acquired conditions and readmissions in the Medicare program. The Hospital Improvement Innovation Networks will work to reduce overall hospital-acquired conditions by 20% and 30-day hospital readmissions by 12%, building on the success of the Partnership for Patients Hospital Engagement Networks and Quality Improvement Organizations. AHA/HRET led the largest HEN projects. “America’s hospitals embrace the ambitious new goals CMS has proposed,” said AHA President and CEO Rick Pollack. “The vast majority of the nation’s 5,000 hospitals were involved in the successful pursuit of the initial Partnership for Patients aims. Our goal is to get to zero incidents. AHA and our members intend to keep an unrelenting focus on providing better, safer care to our patients – working in close partnership with the federal government and with each other.”

Related News Articles

Headline
AHA President and CEO Rick Pollack explains how hospitals have made meaningful progress in patient safety and delivering high-quality care, in a column…
Headline
The Administration for Strategic Preparedness and Response June 25 announced it conducted an exercise transporting simulated patients with high-consequence…
Headline
Ochsner Health's Stephen Saenz, sepsis program manager, and Teresa Arrington, director of robust process improvement for quality and patient safety, reveal how…
Headline
The Centers for Disease Control and Prevention has added new resources for health care providers to its Be Ready for Measles Toolkit. They include a decision…
Headline
There have been 1,168 confirmed cases of measles across 33 states as of June 6 this year, according to the latest data from the Centers for Disease Control and…
Headline
A JAMA study published June 3 found that of 2,237 counties across the U.S., 78% reported declines in vaccination rates for measles, mumps and rubella from 2019…